<DOC>
	<DOCNO>NCT00006156</DOCNO>
	<brief_summary>This purpose study gain information normal ovarian function useful develop test early detection ovarian failure . The ovary produce female hormone , estrogen , important maintain woman 's health . When ovary work properly , problem develop . Unfortunately , test detect ovarian failure early course . By time premature ovarian failure diagnose young woman , two-thirds already develop osteopenia ( loss bone mass ) nearly one ten osteoporosis , great loss bone mineral density weaken bone increase risk fracture . Women normal ovarian function age 18 55 postmenopausal woman 60 year age old may eligible study . Candidates screen medical history , physical examination , blood test vaginal ultrasound examination . For ultrasound study , probe emits sound wave insert vagina , sound wave convert form image ovary . The procedure do empty bladder take 10 minute . After screen visit ( Visit 1 ) , enrol study return NIH Clinical Center follow additional procedure : Visit 2-Will schedule day 3 5 menstrual cycle ( woman still menstruate ) . Participants blood test measure hormone level check pregnancy , another transvaginal ultrasound examination . They receive injection synthetic form follicle stimulate hormone ( FSH ) , hormone body make normally . Visits 3 4-Will schedule 24 36 hour FSH injection give Visit 2 collection blood sample . Visit 5-Will schedule 48 hour FSH injection additional blood sample final transvaginal ultrasound examination .</brief_summary>
	<brief_title>Feasibility Study Development Early Test Ovarian Failure</brief_title>
	<detailed_description>This pilot project test feasibility develop FSH stimulation test . There need sensitive specific marker detect ovarian insufficiency early course . FSH stimulate inhibin B production granulosa cell cohort ovarian follicle ; serum inhibin B turn participates negative feedback loop regulate FSH secretion . This protocol characterize normal FSH-stimulated serum inhibin B response single subcutaneous injection 300 IU human recombinant FSH give day 2 4 menstrual cycle . In preliminary analysis protocol demonstrate FSH-stimulated serum inhibin B level measure 24 hour injection robust marker functional ovarian age ovarian follicle count transvaginal ultrasound , basal serum Mullerian Inhibiting Substance ( MIS ) level , basal serum FSH level . Multiple regression analysis reveal FSH-stimulated inhibin B , FSH-stimulated estradiol , basal FSH contribute significantly ability predict functional ovarian age ( approximated chronological age ) . The result regression equation relate three parameter age correlation coefficient 0.742 coefficient determination 0.551 . The protocol evaluate reproducibility test feasibility generate normative data young woman age 18 25 . The result study may define parameter could lead early diagnosis treatment premature ovarian insufficiency .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<criteria>INCLUSION CRITERIA : A . Women normal ovarian function : Age 18 55 . Normal body mass index ( 1830 kg/m ( 2 ) ) . Normal menstrual cycle ( 2535 day length ) . Ovulatory serum progesterone concentration ( excess 6 ng/mL menstrual cycle precede study cycle ) . B. Postmenopausal woman ( serve negative control ) : Greater equal 60 year age . Proven fertility ( evidenced history pregnancy regardless outcome ) . Normal body mass index ( 1830 kg/m ( 2 ) ) . Naturally menopausal : amenorrhea least one year ; serum FSH great 40 IU/mL . C. Women carrier FMR1 premutations : Age 18 40 . 50 200 CGG repeat . Normal menstrual cycle ( 2535 day length ) . Have previously genetic counseling regard FMR1 status . EXCLUSION CRITERIA : History infertility infertility first degree relative . Acute chronic disease . Menopause due surgery , radiation , chemotherapy . Current use oral contraceptive hormone replacement therapy , use agent within previous 3 month . Use within previous three month medication know affect hypothalamicpituitaryovarian axis ( include overthecounter alternative medicine ) . History excessive exercise ( great 10 hour week ) . Girls exclude data regard FSH use child . Smokers . Pregnant . Breast feeding . Persistent ovarian mass . History tumor ovary , breast , uterus , hypothalamus , pituitary . History breast endometrial cancer . History hypersensitivity recombinant FSH one excipients .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Ovarian Failure</keyword>
	<keyword>Ovary</keyword>
	<keyword>Aging</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Primary Ovarian Insufficiency ( POI )</keyword>
	<keyword>Premature Menopause</keyword>
	<keyword>Premature Ovarian Failure ( POF )</keyword>
</DOC>